Sutherland RL - Search Results

1

Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ. Alles MC, et al. Among authors: sutherland rl. PLoS One. 2009;4(3):e4710. doi: 10.1371/journal.pone.0004710. Epub 2009 Mar 9. PLoS One. 2009. PMID: 19270750 Free PMC article.

2

Cyclins and breast cancer.

Sutherland RL, Musgrove EA. Sutherland RL, et al. J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104. doi: 10.1023/B:JOMG.0000023591.45568.77. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082921 Review.

3

c-Myc overexpression and endocrine resistance in breast cancer.

McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL. McNeil CM, et al. Among authors: sutherland rl. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):147-55. doi: 10.1016/j.jsbmb.2006.09.028. Epub 2006 Oct 18. J Steroid Biochem Mol Biol. 2006. PMID: 17052904

4

Identification of downstream targets of estrogen and c-myc in breast cancer cells.

Musgrove EA, Sergio CM, Anderson LR, Inman CK, McNeil CM, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Sutherland RL. Musgrove EA, et al. Among authors: sutherland rl. Adv Exp Med Biol. 2008;617:445-51. doi: 10.1007/978-0-387-69080-3_43. Adv Exp Med Biol. 2008. PMID: 18497068

5

Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.

Musgrove EA, Sergio CM, Loi S, Inman CK, Anderson LR, Alles MC, Pinese M, Caldon CE, Schütte J, Gardiner-Garden M, Ormandy CJ, McArthur G, Butt AJ, Sutherland RL. Musgrove EA, et al. Among authors: sutherland rl. PLoS One. 2008 Aug 20;3(8):e2987. doi: 10.1371/journal.pone.0002987. PLoS One. 2008. PMID: 18714337 Free PMC article.

6

Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.

Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA. Zardawi SJ, et al. Among authors: sutherland rl. Histol Histopathol. 2009 Mar;24(3):385-98. doi: 10.14670/HH-24.385. Histol Histopathol. 2009. PMID: 19130408 Review.

7

Biological determinants of endocrine resistance in breast cancer.

Musgrove EA, Sutherland RL. Musgrove EA, et al. Among authors: sutherland rl. Nat Rev Cancer. 2009 Sep;9(9):631-43. doi: 10.1038/nrc2713. Nat Rev Cancer. 2009. PMID: 19701242 Review.

8

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

Henshall SM, Afar DE, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench JG, Gardiner-Garden M, Stricker PD, Scher HI, Grygiel JJ, Agus DB, Mack DH, Sutherland RL. Henshall SM, et al. Among authors: sutherland rl. Cancer Res. 2003 Jul 15;63(14):4196-203. Cancer Res. 2003. PMID: 12874026

9

Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.

Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL. Kwong RA, et al. Among authors: sutherland rl. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3705-11. Clin Cancer Res. 2003. PMID: 14506162

10

Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.

Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, Hunter LJ, Sutherland RL, Musgrove EA. Swarbrick A, et al. Among authors: sutherland rl. Oncogene. 2005 Jan 13;24(3):381-9. doi: 10.1038/sj.onc.1208188. Oncogene. 2005. PMID: 15489884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page